Title

Appropriate Use Criteria for the Treatment of Early-Stage Cutaneous Squamous Cell Carcinoma (SCC) Using Image-Guided Superficial Radiation Therapy

Authoring Organization

Publication Month/Year

July 22, 2024

Last Updated Month/Year

August 1, 2024

Document Type

Other

Country of Publication

US

Document Objectives

SCC is the second most commonly diagnosed skin cancer in the United States, with an estimated 1.8 million cases diagnosed each year. In 2022, ~54,000 new cases of head and neck SCCs were diagnosed, and 11,230 SCC-related deaths were reported.6 Survival rates for SCC are dependent on early detection and ensuring that patients have access to various treatment modalities, including noninvasive, radiation-based treatments such as IGSRT, which is 99%+ effective at eradicating SCC and can be safely delivered in the dermatology setting by DART-trained dermatologists and board-certified radiation therapists. More advanced stages of SCC, or those with high-risk or very-high-risk factors such as nerve/nodal involvement, may require combined treatment approaches that could include surgery, radiation therapy, and/or systemic, targeted, immunotherapies.

Inclusion Criteria

Male, Female, Adult, Older adult

Health Care Settings

Ambulatory, Outpatient, Radiology services

Intended Users

Nurse, nurse practitioner, physician, physician assistant, radiology technologist

Scope

Treatment, Management

Diseases/Conditions (MeSH)

D002294 - Carcinoma, Squamous Cell, D018307 - Neoplasms, Squamous Cell

Keywords

squamous cell carcinoma, SCC